Product logins

Find logins to all Clarivate products below.


$24,750.00   |  '

Delayed Sleep-Wake Phase Disorder | Executive Insights | US/EU5 | 2021

  • DSWPD is a type of circadian rhythm sleep-wake disorder in which the sleep-wake cycle is delayed. DSWPD occurs more commonly in adolescents than in adults. In addition, the condition is highly comorbid with some psychiatric conditions, such as MDD and ASD.
  • Although interviewed sleep specialists commonly diagnose DSWPD, they cite challenges in differentiating circadian DSWPD from noncircadian (i.e., behavioral) DSWPD. Interviewed psychiatrists usually consider DSWPD as secondary to a psychiatric disorder.
  • No drug is currently approved for the management of DSWPD in the United States and EU5. Melatonin and some nonpharmacological approaches (e.g., light therapy) are commonly utilized in the treatment of DSWPD. However, the patient journey may differ depending on the presence or absence of a comorbid psychiatric disorder.
  • Interviewed physicians cite multiple areas of unmet need in DSWPD, so opportunities exist for drug development in DSWPD. Of note, interviewed physicians have high expectations for an emerging drug in DSWPD.

Related Market Assessment Reports

Report
Non-Small-Cell Lung Cancer – Unmet Need – Unmet Need – Metastatic NSCLC without driver mutations (US EU)
First-line treatment for non-small-cell lung cancer (NSCLC) patients without driver mutations typically includes an immune checkpoint inhibitor, with or without platinum-based chemotherapy,…
Report
Psoriasis – Unmet Need – Unmet Need – Moderate to Severe Psoriasis (US/EU)
Topical therapies are the backbone of psoriasis management; however, they are often inadequate for patients with moderate to severe disease, who typically require systemic treatment. While…
Report
Eosinophilic Esophagitis – Unmet Need – Unmet Need – Eosinophilic Esophagitis (US/EU)
Standard treatments for eosinophilic esophagitis (EoE) typically include proton pump inhibitors (PPIs) and swallowed topical steroids. Although these therapies can alleviate EoE symptoms, their…
Report
Breast Cancer – Geographic Focus: China – China In-Depth – Breast Cancer
China’s breast cancer market continues to evolve rapidly, driven by rising incidence and expanding systemic treatment options. Several new and emerging therapies are expected to gain approval for…
Report
Chronic Obstructive Pulmonary Disease – Unmet Need – Unmet Need – Severe to Very Severe Chronic Obstructive Pulmonary Disease (US EU)
The severe to very severe chronic COPD market is crowded, with numerous LAMA, LABA/ICS, LABA/LAMA, and triple LABA/LAMA/ICS inhalers competing for use. Although dual and triple longacting…